Dyskinesia of esophagus
diseaseOn this page
Also known as esophageal motility disorderoesophageal dysmotilityoesophageal motor disorder
Summary
Dyskinesia of esophagus (MONDO:0004729) is a disease and 26 clinical trials. Top therapeutic interventions include prucalopride, codeine phosphate, and famotidine. A subtype of esophageal disorder — broader associated-gene and molecular evidence is on the parent page (see Disease family below).
At a glance
- Clinical trials: 26
Clinical features
No curated clinical features (Orphanet) for this disease.
Identifiers
Disease identifiers
| Field | Value |
|---|---|
| Canonical name | dyskinesia of esophagus |
| Mondo ID | MONDO:0004729 |
| MeSH | D015154 |
| DOID | DOID:9192 |
| ICD-10-CM | K22.4 |
| ICD-11 | 581725607 |
| SNOMED CT | 266434009 |
| UMLS | C0014858 |
| MedGen | 41868 |
| Is cancer (heuristic) | no |
Also known as: dyskinesia of esophagus · esophageal motility disorder · oesophageal dysmotility · oesophageal motor disorder
Disease family
This is a subtype of esophageal disorder. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.
Classification path: disease › human disease › disease by body system or component › digestive system disorder › upper digestive tract disorder › esophageal disorder › dyskinesia of esophagus
Related subtypes (19): esophageal atresia, esophageal varices, esophagitis, megaesophagus, esophageal tuberculosis, esophageal leukoplakia, esophageal diverticulosis, gastroesophageal reflux disease, esophageal atresia/tracheoesophageal fistula, achalasia, Barrett esophagus, esophageal duplication cyst, tubular duplication of the esophagus, laryngotracheoesophageal cleft, isolated tracheo-esophageal fistula, congenital esophageal diverticulum, neoplasm of esophagus, esophageal ulcer, congenital esophageal stenosis
Genetics & variants
GWAS landscape
No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.
Variant details and genetic-evidence tiers
No tiered GWAS variants or ClinVar records for this disease.
Genes & proteins
No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).
Function
No pathway enrichment — requires an associated-gene cohort.
Therapeutics
No druggable-target or therapeutic data for this disease’s cohort.
Clinical trials & evidence
Clinical trials
Clinical trials: 26.
Phase distribution (across all retrieved trials)
| Phase | Trials |
|---|---|
| Not specified | 20 |
| PHASE4 | 3 |
| PHASE2 | 3 |
Top trials by phase / activity
| NCT | Phase | Status | Title |
|---|---|---|---|
| NCT05455359 | PHASE4 | RECRUITING | Gastrointestinal Dysmotility on Aspiration Risk |
| NCT02736734 | PHASE4 | COMPLETED | The Effect of Corticotrophin-releasing Hormone (CRH) on Esophageal Motility in Healthy Volunteers |
| NCT03784105 | PHASE4 | COMPLETED | Codeine on Pharyngeal and Esophageal Motility |
| NCT01302301 | PHASE2 | UNKNOWN | Endolumenal Partial Myotomy for Esophageal Motility Disorders |
| NCT01448993 | PHASE2 | COMPLETED | Effect of Azithromycin on Oesophageal Hypomotility |
| NCT05604261 | PHASE2 | UNKNOWN | A Study of Anaprazole Sodium Enteric-coated Tablets in the Treatment of Reflux Esophagitis |
| NCT05132816 | Not specified | RECRUITING | High Resolution Manometry After Partial Fundoplication for Gastro-oesophageal Reflux |
| NCT05272046 | Not specified | ACTIVE_NOT_RECRUITING | Monopolar and Bipolar Current RFA Knife in POEM |
| NCT05380791 | Not specified | RECRUITING | Effect of Esophageal Contractile Reserve on Changes in Esophageal Motility and Symptoms After ARS in Patients With GERD |
| NCT06878586 | Not specified | NOT_YET_RECRUITING | Diagnostic Evaluation of Esophageal Motility Disorders Using the Chicago IV Protocol in Egypt |
| NCT07496840 | Not specified | RECRUITING | Clinical Outcomes, Safety, and Effectiveness of Speedboat UltraSlim™ in Per-Oral Endoscopic Myotomy (POEM) |
| NCT01234428 | Not specified | COMPLETED | Esophageal Dysmotility and Dilatation After Laparoscopic Gastric Banding |
| NCT01447823 | Not specified | UNKNOWN | Observational Field Study of Acute Esophageal Food Bolus Impaction by Mean Esophageal Manometry and 24h-pH-monitoring |
| NCT01658865 | Not specified | UNKNOWN | Assessment of Esophageal Motility With Transnasal Endoscopy |
| NCT02663206 | Not specified | WITHDRAWN | Peroral Endoscopic Myotomy Versus Botulinum Toxin Injection in Spastic Esophageal Disorders |
| NCT03012854 | Not specified | UNKNOWN | Different Surgical Procedures of Peroral Endoscopic Myotomy(POEM) for Esophageal Achalasia |
| NCT03100357 | Not specified | UNKNOWN | Changes in Esophageal Motility and Swallowing Symptoms After Thyroid Surgery |
| NCT03347903 | Not specified | COMPLETED | Prevalence and Clinical Characteristics of Patients With Jackhammer Esophagus and Symptoms of Gastroesophageal Reflux Disease |
| NCT03662490 | Not specified | UNKNOWN | Correlation Between Clinical Signs and High-resolution Manometry Data in Children |
| NCT03904004 | Not specified | UNKNOWN | Pressure and Flow Study Before and After Treatments for EMD. The pFlow Study |
| NCT05402462 | Not specified | UNKNOWN | Esophageal Motility Disorders in Patients With Non-cardiac Chest Pain at Assiut University Hospital |
| NCT05913011 | Not specified | UNKNOWN | Prevalence of IEM Among Upper GIT Symptoms |
| NCT06314893 | Not specified | TERMINATED | Establishing a Correlation Between HRM and UGI MM Studies |
| NCT06329583 | Not specified | COMPLETED | Establishing Pressures at the EGJ During Diaphragmatic Breathing Using High-resolution Esophageal Manometry |
| NCT06629025 | Not specified | COMPLETED | The Clinical Manifestation and Prognosis of Pediatric Esophageal Motility Disorders |
| NCT06918730 | Not specified | COMPLETED | U-POEM vs CO2-POEM |
Drugs tested across these trials (top 30)
| Molecule | Max phase | Trials referencing |
|---|---|---|
| PRUCALOPRIDE | 4 | 2 |
| CODEINE PHOSPHATE | 4 | 1 |
| FAMOTIDINE | 4 | 1 |
| RABEPRAZOLE | 4 | 1 |
| ANAPRAZOLE | 3 | 1 |
| CHEMBL4747028 | 0 | 1 |
Related Atlas pages
- Drugs: Prucalopride, Codeine Phosphate, Famotidine, Rabeprazole, Anaprazole